SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule
ARQL 20.000.0%Jan 16 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (51)3/7/1997 4:51:00 PM
From: James Silverman   of 399
 
Touche indeed.

Friday March 7 3:48 PM EDT

ArQule, Inc. Files Registration Statement with SEC for
Secondary Public Offering

MEDFORD, Mass., March 7 /PRNewswire/ -- ArQule Inc today announced it has filed a
registration statement with the Securities and Exchange Commission (SEC) relating to a public
offering of 2,000,000 shares of its common stock, of which 1,632,500 shares are to be sold by
ArQule and 367,500 shares are to be sold by certain stockholders. Hambrecht & Quist LLC,
Oppenheimer & Co., Inc. and Vector Securities International, Inc. will serve as underwriters for the
offering. ArQule will also grant the underwriters an option to purchase an additional 300,000 shares
of common stock solely to cover over-allotments, if any.

A copy of the prospectus, when available, may be obtained from Hambrecht & Quist, LLC, One
Bush Street, San Francisco, California 94104, 415-576-3300.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext